TY - JOUR

T1 - The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

AU - Zuberbier, Torsten

AU - Abdul Latiff, Amir Hamzah

AU - Abuzakouk, Mohamed

AU - Aquilina, Susan

AU - Asero, Riccardo

AU - Baker, Diane

AU - Ballmer-Weber, Barbara

AU - Bangert, Christine

AU - Ben-Shoshan, Moshe

AU - Bernstein, Jonathan A.

AU - Bindslev-Jensen, Carsten

AU - Brockow, Knut

AU - Brzoza, Zenon

AU - Chong Neto, Herberto Jose

AU - Church, Martin K.

AU - Criado, Paulo R.

AU - Danilycheva, Inna V.

AU - Dressler, Corinna

AU - Ensina, Luis Felipe

AU - Fonacier, Luz

AU - Gaskins, Matthew

AU - Gáspár, Krisztian

AU - Gelincik, Aslı

AU - Giménez-Arnau, Ana

AU - Godse, Kiran

AU - Gonçalo, Margarida

AU - Grattan, Clive

AU - Grosber, Martine

AU - Hamelmann, Eckard

AU - Hébert, Jacques

AU - Hide, Michihiro

AU - Kaplan, Allen

AU - Kapp, Alexander

AU - Kessel, Aharon

AU - Kocatürk, Emek

AU - Kulthanan, Kanokvalai

AU - Larenas-Linnemann, Désirée

AU - Lauerma, Antti

AU - Leslie, Tabi A.

AU - Magerl, Markus

AU - Makris, Michael

AU - Meshkova, Raisa Y.

AU - Metz, Martin

AU - Micallef, Daniel

AU - Mortz, Charlotte G.

AU - Nast, Alexander

AU - Oude-Elberink, Hanneke

AU - Pawankar, Ruby

AU - Pigatto, Paolo D.

AU - Ratti Sisa, Hector

AU - Rojo Gutiérrez, María Isabel

AU - Saini, Sarbjit S.

AU - Schmid-Grendelmeier, Peter

AU - Sekerel, Bulent E.

AU - Siebenhaar, Frank

AU - Siiskonen, Hanna

AU - Soria, Angele

AU - Staubach-Renz, Petra

AU - Stingeni, Luca

AU - Sussman, Gordon

AU - Szegedi, Andrea

AU - Thomsen, Simon Francis

AU - Vadasz, Zahava

AU - Vestergaard, Christian

AU - Wedi, Bettina

AU - Zhao, Zuotao

AU - Maurer, Marcus

N1 - Publisher Copyright: © 2021 GA²LEN. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

PY - 2022

Y1 - 2022

N2 - This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA²LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international societies and from 31 countries. The consensus conference was held on 3 December 2020. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell–driven disease that presents with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

AB - This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA²LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international societies and from 31 countries. The consensus conference was held on 3 December 2020. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell–driven disease that presents with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

KW - angioedema

KW - consensus

KW - evidence-based

KW - hives

KW - itch

KW - mast cell

KW - urticaria

KW - wheal

UR - http://www.scopus.com/inward/record.url?scp=85117272768&partnerID=8YFLogxK

U2 - 10.1111/all.15090

DO - 10.1111/all.15090

M3 - Journal article

C2 - 34536239

AN - SCOPUS:85117272768

VL - 77

SP - 734

EP - 766

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 3

ER -